Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis

International Journal of Cancer

Volumn 127, Issue 10, 2010, Pages 2279-2291

  Clere, Nicolas ^a   Corre, Isabelle ^b   Faure, Sébastien ^a   Guihot, Anne Laure ^a   Vessiãres, Emilie ^a   Chalopin, Marie ^a   Morel, Alain ^c   Coqueret, Olivier ^c   Hein, Lutz ^e   Delneste, Yves ^d   Paris, François ^b   Henrion, Daniel ^a  

^a Universite d'Angers   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c UMR INSERM U892 CNRS 6299   (France)

^d UNIVERSITÉ D'ANGERS   (France)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

angiogenesis; AT2R; cell proliferation; tumor growth

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; CD31 ANTIGEN; KI 67 ANTIGEN; VASCULOTROPIN; 3 METHYLCHOLANTHRENE; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN 3 MCA; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; RECEPTOR BLOCKING; TUMOR VASCULARIZATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL GROWTH; CELL TRANSFORMATION; DRUG ANTAGONISM; DRUG EFFECT; GENE DELETION; GENETICS; LEWIS CARCINOMA; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROSARCOMA; GENE DELETION; IMIDAZOLES; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954624561     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25234     Document Type: Article

References (42)

1. Dzau VJ, Mukoyama M, Pratt RE,. Molecular biology of angiotensin receptors: target for drug research? J Hypertens Suppl 1994; 12: S1-S5.
2. Inagami T,. Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol 1999; 10 (Suppl 11): S2-S7.
3. Horiuchi M, Lehtonen JY, Daviet L,. Signaling mechanism of the AT2 angiotensin II receptor: crosstalk between AT1 and AT2 receptors in cell growth. Trends Endocrinol Metab 1999; 10: 391-6.
4. Faure S, Bureau A, Oudart N, Javellaud J, Fournier A, Achard JM,. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J Hypertens 2008; 26: 2008-15.
5. Kaschina E, Unger T,. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003; 12: 70-88.
6. Widdop RE, Jones ES, Hannan RE, Gaspari TA,. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 2003; 140: 809-24.
7. Henrion D, Kubis N, Levy BI,. Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 2001; 38: 1150-7.
8. Tamarat R, Silvestre JS, Durie M, Levy BI,. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002; 82: 747-56.
9. Deshayes F, Nahmias C,. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005; 16: 293-9.
10. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T,. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112: 67-75.
11. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M,. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002; 294: 441-7.
12. Huang W, Wu YL, Zhong J, Jiang FX, Tian XL, Yu LF,. Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts. Dig Dis Sci 2008; 53: 1206-10.
13. Rivera E, Arrieta O, Guevara P, Duarte-Rojo A, Sotelo J,. AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 2001; 85: 1396-9.
14. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F,. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 2005; 11: 2686-94.
15. Pawlikowski M,. Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas. Folia Histochem Cytobiol 2006; 44: 173-7.
16. Arrieta O, Pineda-Olvera B, Guevara-Salazar P, Hernandez-Pedro N, Morales-Espinosa D, Ceron-Lizarraga TL, Gonzalez-De la Rosa CH, Rembao D, Segura-Pacheco B, Sotelo J,. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. Br J Cancer 2008; 99: 160-6.
17. Kanehira T, Tani T, Takagi T, Nakano Y, Howard EF, Tamura M,. Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-Î-dependent cell growth attenuation. Cancer Res 2005; 65: 7660-5.
18. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70.
19. Folkman J,. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
20. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK,. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995; 377: 744-7.
21. Brattain MG, Strobel-Stevens J, Fine D, Webb M, Sarrif AM,. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res 1980; 40: 2142-6.
22. Sylvain V, Lafarge S, Bignon YJ,. Molecular pathways involved in response to ionizing radiation of ID-8 mouse ovarian cancer cells expressing exogenous full-length Brca1 or truncated Brca1 mutant. Int J Oncol 2001; 19: 599-607.
23. Arrieta O, Guevara P, Escobar E, Garcia-Navarrete R, Pineda B, Sotelo J,. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 2005; 92: 1247-52.
24. Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, Kato S, Kubota Y,. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther 2005; 4: 1699-709.
25. De Paepe B, Verstraeten VM, De Potter CR, Bullock GR,. Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem Cell Biol 2002; 117: 13-19.
26. Fogarty DJ, Sanchez-Gomez MV, Matute C,. Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro. Glia 2002; 39: 304-13.
27. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, Nguyen G, Wostl W, Maerki HP, Janzer RC, Corvol P, Gasc JM,. Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 2004; 90: 1059-68.
28. Takagi T, Nakano Y, Takekoshi S, Inagami T, Tamura M,. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2002; 23: 1235-41.
29. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T,. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50.
30. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y,. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003; 2: 1139-47.
31. Unger T,. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 1999; 17: 1775-86.
32. Cao Z, Dean R, Wu L, Casley D, Cooper ME,. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999; 34: 408-14.
33. Cao Z, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME,. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int 2000; 58: 2437-51.
34. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL,. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996; 98: 418-25.
35. Janiak P, Pillon A, Prost JF, Vilaine JP,. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992; 20: 737-45.
36. Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M,. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 2003; 17: 2061-7.
37. Silvestre JS, Tamarat R, Senbonmatsu T, Ichiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Levy BI,. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2002; 90: 1072-9.
38. Zhang X, Lassila M, Cooper ME, Cao Z,. Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension 2004; 43: 276-81.
39. Rizkalla B, Forbes JM, Cooper ME, Cao Z,. Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. J Am Soc Nephrol 2003; 14: 3061-71.
40. Mukhopadhyay D, Datta K,. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors. Semin Cancer Biol 2004; 14: 123-30.
41. Richard DE, Vouret-Craviari V, Pouyssegur J,. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 2001; 20: 1556-62.
42. Ager EI, Neo J, Christophi C,. The renin-angiotensin system and malignancy. Carcinogenesis 2008; 29: 1675-84.